Literature DB >> 16448668

Idiopathic neuropathy, prediabetes and the metabolic syndrome.

A Gordon Smith1, J Robinson Singleton.   

Abstract

Peripheral neuropathy is a common problem encountered by neurologists and primary care physicians. While there are many causes for peripheral neuropathy, none can be identified in a large percentage of patients ("idiopathic neuropathy"). Despite its high prevalence, idiopathic neuropathy is poorly studied and understood. There is evolving evidence that impaired glucose tolerance (prediabetes) is associated with idiopathic neuropathy. Preliminary data from a multicenter study of diet and exercise in prediabetes (the Impaired Glucose Tolerance Neuropathy Study) suggests a diet and exercise counseling regimen based on the Diabetes Prevention Program results in improved metabolic measures and small fiber function. Prediabetes is part of the Metabolic Syndrome, which also includes hypertension, hyperlipidemia and obesity. Individual aspects of the Metabolic Syndrome influence risk and progression of diabetic neuropathy and may play a causative role in neuropathy both for those with prediabetes, and those with otherwise idiopathic neuropathy. Thus, a multifactorial treatment approach to individual components of Metabolic Syndrome may slow prediabetic neuropathy progression or result in improvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448668     DOI: 10.1016/j.jns.2005.11.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  39 in total

1.  Physiological correlates of age-related decline in vibrotactile sensitivity.

Authors:  Nandini Deshpande; E Jeffery Metter; Shari Ling; Robin Conwit; Luigi Ferrucci
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

Review 2.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

Review 4.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

5.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

Review 6.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

7.  Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlife.

Authors:  Kelly R Ylitalo; William H Herman; Siobán D Harlow
Journal:  Am J Epidemiol       Date:  2013-03-22       Impact factor: 4.897

8.  Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology.

Authors:  Christopher H Gibbons; Roy Freeman; Aristidis Veves
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

Review 9.  [Treatment options in painful diabetic polyneuropathy].

Authors:  Juan J Archelos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

10.  Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance.

Authors:  Alistair Q Green; Singhan Krishnan; Francis M Finucane; Gerry Rayman
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.